Internal Medicine, Medical Oncology · New York, NY
NPI
1174594113
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave
New York, NY, 10021
Phone (646) 227-3813
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
670 services
Medicare patients, 2024
168
Average age 75
Drug cost, 2024
$5.0M
979 prescriptions
Company payments, 2025
$5,004
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark G Kris was code 99214 (office e&m - established), 338 times for 123 patients. In total Mark G Kris billed 670 services in 5 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 338 | 123 | $82.37 | $28K |
| 99213 Office E&M - Established | Office | 225 | 105 | $57.05 | $13K |
| 99215 Office E&M - Established | Office | 73 | 45 | $128.44 | $9,376 |
| 99205 Office E&M - New | Office | 32 | 32 | $147.29 | $4,713 |
By year: 2022 $71K for 885 services; 2023 $62K for 711 services; 2024 $55K for 670 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark G Kris prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 214 prescriptions and refills. In total Mark G Kris wrote 979 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 214 | 220 | 26 | $3.6M |
| Omeprazole Generic | 66 | 96 | 25 | $659 |
| Alecensa Alectinib Hcl | 48 | 48 | Under 11 | $679K |
| Dexamethasone Generic | 43 | 45 | 24 | $563 |
| Ondansetron Hcl Generic | 40 | 40 | 22 | $307 |
| Prednisone Generic | 36 | 45 | 13 | $274 |
| Famotidine Generic | 32 | 42 | 11 | $224 |
| Eliquis Apixaban | 29 | 30 | 11 | $17K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 19 | 19 | Under 11 | $471 |
| Folic Acid Generic | 18 | 26 | Under 11 | $56.37 |
| Alclometasone Dipropionate Generic | 17 | 17 | Under 11 | $589 |
| Olanzapine Generic | 17 | 24 | Under 11 | $202 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 16 | 16 | Under 11 | $500 |
| Megestrol Acetate Generic | 13 | 13 | Under 11 | $1,165 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 13 | 16 | Under 11 | $95.6 |
Brand drugs: 372 claims; generic drugs: 607 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark G Kris $5,004 ($5,004 in general payments such as food, travel and fees) from 4 companies. The largest payer was Merck Sharp & Dohme LLC with $1,830.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.